AzTrials
AzTrials

Soft Tissue DefectNCT01871103

The Dorsal Homodigital Island Flap Based on the Dorsal Branch of the Digital Artery: A Review of 171 Cases

A study testing The dorsal homodigital island flap in people with Soft Tissue Defect and Sensory Reconstruction of Digits, run by The Second Hospital of Tangshan at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Soft tissue reconstruction in the finger continues to evolve. The dorsum of the finger is a reliable flap donor site in reconstructive hand surgery because of its similar quality to the original. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
What is being tested?
The dorsal homodigital island flap
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
173 participants
Where
1 siteChina
Study dates
Jan 2006to Mar 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • the soft tissue defect in one finger or in multiple fingers
  • a defect > 1.5 cm and < 3 cm in length
  • necessity to preserve finger length
  • a patient between 15 and 60 years of age

Who cannot join

  • injuries to the dorsum of the finger or to the course of the vascular pedicle that precluded its use as the donor
  • a defect≤1.5 cm or ≥3 cm in length
  • a soft tissue defect of the thumb

Trial locations and contacts

1 site in 1 country.

China1 site
  • The Second Hospital of Tangshan

    Tangshan, Hebei, 063000

Other trials in China

About this study

Soft tissue reconstruction in the finger continues to evolve. The dorsum of the finger is a reliable flap donor site in reconstructive hand surgery because of its similar quality to the original. The dorsal homodigital island flap can be used as a reliable alternative for reconstructing small to moderate defects of the fingers. In this retrospective study, the investigators would evaluate the efficacy of the technique for tissue reconstruction in different regions of the finger, with an emphasis on sensibility, pain and donor site morbidity.

Read the detailed description

At final follow-up, sensory restoration of the flap is measured using the static 2-point discrimination test and Semmes-Weinstein monofilament test. We evaluate pain sensations of the reconstructed fingers and donor sites with a visual analog scale. The system consist of a 10 cm line that is grouped into mild (0-3 cm), moderate (4-6 cm) and severe (7-10 cm). Active motion of the joints is measured using a goniometer. The motion arcs of the reconstructed fingers are compared with the opposite side.

Being tested
The dorsal homodigital island flap
Keywords
Soft tissue defect, dorsal branch of the digital artery, dorsal branch of the digital nerve, dorsal homodigital island flap

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The dorsal homodigital island flapProcedure or surgery

    The dorsal homodigital island flap is used for tissue reconstruction in different regions of the finger.

Study groups in NCT01871103
Study groupRoleWhat they receive
Surgical flapOtherThe dorsal homodigital island flap is a perforator type flap based on the DB, which uses the dorsal skin of the injured finger to provide soft tissue coverage for a volar defect.
Receives: Procedure: The dorsal homodigital island flap

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Static 2-point discrimination test

    The test point is at the center of the flap. Each area was tested 3 times with a Discriminator (Ali Med, Dedham, MA). We stop at 4mm as a limit of 2PD and considered this normal.

    Measured: 18 months to 24 months

Secondary outcomes (1)
  1. Cold intolerance

    We access the cold intolerance of the injured and donor fingers using the self-administered Cold Intolerance Severity Score questionnaire10 that is rated into mild, moderate, severe, and extreme (0-25, 26-50, 51-75 and 76-100).

    Measured: 18 months to 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2013 (estimated)
  2. Study startJan 2006
  3. Primary completionJan 2009
  4. Study completionMar 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
173 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01871103
Sponsor's protocol ID
HBTS1306017
Status last verified
Jan 2007
First submitted
3 Jun 2013
Last updated
6 Jun 2013
Results posted
No
Data monitoring committee
Yes

Publications

  • Chen C, Tang P, Zhang X. Sensory reconstruction of a finger pulp defect using a dorsal homodigital island flap. Plast Reconstr Surg. 2012 Nov;130(5):1077-1086. doi: 10.1097/PRS.0b013e318267ef99.

    PubMed 22777035
  • Chen C, Tang P, Zhang X. The dorsal homodigital island flap based on the dorsal branch of the digital artery: a review of 166 cases. Plast Reconstr Surg. 2014 Apr;133(4):519e-529e. doi: 10.1097/PRS.0000000000000016.

    PubMed 24675204

Questions about this trial

What is this clinical trial studying?

A study testing The dorsal homodigital island flap in people with Soft Tissue Defect and Sensory Reconstruction of Digits, run by The Second Hospital of Tangshan at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jun 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Static 2-point discrimination test (time frame: 18 months to 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01871103, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in